NDC-1308 a Biotherapeutic for ARDS and Other Pulmonary Viruses

NDC-1308 a Biotherapeutic for ARDS and Other Pulmonary Viruses

(Originally published on Nov 12, 2020) To win the battle with SARS-CoV-2 ENDECE a revolutionary biotech company based in Portland, OR. has developed a biotherapeutic designed to regain control of immune response preventing ARDS (Acute Respiratory Distress Syndrome)....